What “Moonshots” are
Moonshots are the speculative end of the market — pre-profit, fast-growing, heavily-discussed names (think emerging tech, clinical biotech, and other high-variance stories). They are the stocks people talk about precisely because the range of outcomes is enormous: a few multiply, and many do not survive.
How the list is built
We rank the speculative universe by a simple upside lens — the magnitude of revenue growth plus analyst price-target upside — with light guardrails that screen out names with blown-up balance sheets or illusory, low-base growth. It is intentionally a different lens from our main model, which scores companies on durable fundamentals.
Why it is separate from our rankings
This list is not part of the tracked Bull Rankings model, and it does not appear in our track record. In our own back-testing, scoring stocks this way performed poorly — speculative “lottery” names carry a wide and often negative range of returns. We surface them here for interest and discussion only. Treat every name as high-risk, do your own research, and never invest money you can't afford to lose.